Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Propranolol

M&A STATUS
Buyout/LBO LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Provider of pharmaceutical products. The company provides generic propranolol hydrochloride extended release capsules used to treat hypertension.

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-backed
Primary Industry
Drug Delivery
Other Industries
Pharmaceuticals
Acquirer
Primary Office
  • 909 Third Avenue
  • New York, NY 10022
  • United States

Propranolol Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Propranolol‘s full profile, request access.

Request full access to PitchBook

Propranolol Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Propranolol‘s full profile, request access.

Request full access to PitchBook